英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
Aprutumab |
阿普盧妥單抗 |
1634620-63-5 |
詳細(xì)
|
Camrelizumab |
Camrelizumab |
1798286-48-2 |
詳細(xì)
|
Vunakizumab |
Vunakizumab |
1792181-33-9 |
詳細(xì)
|
Utomilumab |
烏托魯單抗 |
1417318-27-4 |
詳細(xì)
|
Rosmantuzumab |
Rosmantuzumab |
1684393-04-1 |
詳細(xì)
|
Lutikizumab |
Lutikizumab |
1791411-57-8 |
詳細(xì)
|
Dezamizumab |
Dezamizumab |
1662664-56-3 |
詳細(xì)
|
Telisotuzumab |
Telisotuzumab |
1781223-80-0 |
詳細(xì)
|
Azintuxizumab |
Azintuxizumab |
1826819-57-1 |
詳細(xì)
|
Gedivumab |
Gedivumab |
1807954-17-1 |
詳細(xì)
|
Lesofavumab |
Lesofavumab |
1807960-57-1 |
詳細(xì)
|
Flotetuzumab |
Flotetuzumab |
1664355-28-5 |
詳細(xì)
|
Brazikumab |
Brazikumab |
1610353-18-8 |
詳細(xì)
|
Ranevetmab |
Ranevetmab |
1632282-27-9 |
詳細(xì)
|
Sacituzumab |
沙西妥珠單抗 |
1796566-95-4 |
詳細(xì)
|
Losatuxizumab |
Losatuxizumab |
1801544-27-3 |
詳細(xì)
|
Varisacumab |
Varisacumab |
1610010-60-0 |
詳細(xì)
|
Letolizumab |
Letolizumab |
1450981-87-9 |
詳細(xì)
|
Suvratoxumab |
Suvratoxumab |
1629620-18-3 |
詳細(xì)
|
Frunevetmab |
夫盧維單抗 |
1708936-80-4 |
詳細(xì)
|
Garetosmab |
GARETOSMAB (加托索單抗 ) |
2097125-54-5 |
詳細(xì)
|
Tomaralimab |
TOMARALIMAB (托拉利單抗 ) |
1449294-76-1 |
詳細(xì)
|
Maftivimab |
MAFTIVIMAB (瑪替韋單抗 ) |
2135632-36-7 |
詳細(xì)
|
Crizanlizumab |
Crizanlizumab |
1690318-25-2 |
詳細(xì)
|
Emapalumab |
依瑪魯單抗 |
1709815-23-5 |
詳細(xì)
|
Lacnotuzumab |
Lacnotuzumab |
1831128-32-5 |
詳細(xì)
|
Oleclumab |
奧來(lái)魯單抗 |
1803176-05-7 |
詳細(xì)
|
Research Grade Zanidatamab |
ZANIDATAMAB (澤尼達(dá)妥單抗 ) |
2169946-15-8 |
詳細(xì)
|
Timigutuzumab |
Timigutuzumab |
1665274-14-5 |
詳細(xì)
|
Tomuzotuximab |
Tomuzotuximab |
1646321-00-7 |
詳細(xì)
|
Larcaviximab |
Larcaviximab |
1792982-56-9 |
詳細(xì)
|
Porgaviximab |
Porgaviximab |
1792982-55-8 |
詳細(xì)
|
Cosfroviximab |
Cosfroviximab |
1792982-57-0 |
詳細(xì)
|
Gilvetmab |
Gilvetmab |
1808081-43-7 |
詳細(xì)
|
Selicrelumab |
塞魯單抗 |
1622140-49-1 |
詳細(xì)
|
Sirtratumab |
Sirtratumab |
1824663-82-2 |
詳細(xì)
|
Research Grade Gimsilumab |
瑾司魯單抗 |
1648796-29-5 |
詳細(xì)
|
alacotuzumab |
Talacotuzumab |
1826831-79-1 |
詳細(xì)
|
Research Grade Zolbetuximab |
佐妥昔單抗 |
1496553-00-4 |
詳細(xì)
|
Gatipotuzumab |
Gatipotuzumab |
1264737-26-9 |
詳細(xì)
|
Research Grade Bemarituzumab |
貝馬里妥珠單抗 |
1952272-74-0 |
詳細(xì)
|
Research Grade Mosunetuzumab |
莫妥珠單抗 |
1905409-39-3 |
詳細(xì)
|
Loncastuximab |
Loncastuximab |
1875032-68-0 |
詳細(xì)
|
Research Grade Ladiratuzumab |
LADIRATUZUMAB (ANTI-SLC39A6) |
1629760-28-6 |
詳細(xì)
|
Research Grade Atidortoxumab |
阿度尤單抗 |
1939108-95-8 |
詳細(xì)
|
Berlimatoxumab |
Berlimatoxumab |
1939109-24-6 |
詳細(xì)
|
Tiragolumab |
替瑞利尤單抗 |
1918185-84-8 |
詳細(xì)
|
Ianalumab |
Ianalumab |
1929549-92-7 |
詳細(xì)
|
Research Grade Prasinezumab |
普尼珠單抗 |
1960462-19-4 |
詳細(xì)
|
Research Grade Iladatuzumab |
|
1906205-76-2 |
詳細(xì)
|
Cofetuzumab |
Cofetuzumab |
1869928-62-0 |
詳細(xì)
|
Research Grade Tibulizumab |
Tibulizumab |
1849636-24-3 |
詳細(xì)
|
Cibisatamab |
賽必妥單抗 |
2101242-53-7 |
詳細(xì)
|
Relatlimab |
Relatlimab |
1673516-98-7 |
詳細(xì)
|
Ontamalimab |
Ontamalimab |
2098790-40-8 |
詳細(xì)
|
Netakimab |
Netakimab |
1796570-08-5 |
詳細(xì)
|
Crovalimab |
可伐利單抗 |
1917321-26-6 |
詳細(xì)
|
Research Grade Romilkimab |
若奇單抗 |
1399584-78-1 |
詳細(xì)
|
Research Grade Cusatuzumab |
古妥珠單抗 |
1399546-01-0 |
詳細(xì)
|
Research Grade Faricimab |
法瑞西單抗 |
1607793-29-2 |
詳細(xì)
|
Zenocutuzumab |
Zenocutuzumab |
1969309-56-5 |
詳細(xì)
|
Sutimlimab |
蘇替莫單抗 |
2049079-64-1 |
詳細(xì)
|
Research Grade Etigilimab |
艾替利單抗 |
2044984-83-8 |
詳細(xì)
|
Research Grade Abrezekimab |
阿澤奇單抗 |
2043952-59-4 |
詳細(xì)
|
Research Grade Vopratelimab |
伏派利單抗 |
2039148-04-2 |
詳細(xì)
|
Research Grade Iscalimab |
伊卡利單抗 |
2031153-61-2 |
詳細(xì)
|
Research Grade Bersanlimab |
BERSANLIMAB單抗 |
1987854-08-9 |
詳細(xì)
|
Research Grade Tepoditamab |
|
2044679-53-8 |
詳細(xì)
|
Research Grade Enapotamab |
ENAPOTAMAB單抗 |
1912423-61-0 |
詳細(xì)
|
Research Grade Mitazalimab |
化合物 MITAZALIMAB |
2055640-86-1 |
詳細(xì)
|
Onvatilimab |
奧瓦利單抗 |
1969313-51-6 |
詳細(xì)
|
Research Grade Imaprelimab |
伊普利單抗 |
2014343-04-3 |
詳細(xì)
|
Cetrelimab |
Cetrelimab |
2050478-92-5 |
詳細(xì)
|
Mezagitamab |
MEZAGITAMAB (邁澤妥單抗 ) |
2227490-52-8 |
詳細(xì)
|
Gancotamab |
Gancotamab |
1509928-00-0 |
詳細(xì)
|
Research Grade Temelimab |
替西木單抗 |
1393641-34-3 |
詳細(xì)
|
Toripalimab |
特瑞普利單抗 |
1924598-82-2 |
詳細(xì)
|
Rolinsatamab |
Rolinsatamab |
2095467-30-2 |
詳細(xì)
|
Tabituximab |
Tabituximab |
1644134-10-0 |
詳細(xì)
|
Sintilimab |
信迪利單抗 |
2072873-06-2 |
詳細(xì)
|
Orilanolimab |
奧諾利單抗 |
2066544-85-0 |
詳細(xì)
|
Research Grade Omburtamab |
奧博妥單抗 |
1895083-75-6 |
詳細(xì)
|
Research Grade Prolgolimab |
帕洛利單抗 |
2093956-19-3 |
詳細(xì)
|
Osocimab |
Osocimab |
2056878-75-0 |
詳細(xì)
|
Research Grade Zampilimab |
|
2098280-42-1 |
詳細(xì)
|
Research Grade Gosuranemab |
|
1788032-39-2 |
詳細(xì)
|
Marstacimab |
Marstacimab |
1985638-39-8 |
詳細(xì)
|
Nirsevimab |
Nirsevimab |
1989556-22-0 |
詳細(xì)
|
Frovocimab |
Frovocimab |
1643672-70-1 |
詳細(xì)
|
Dostarlimab |
Dostarlimab |
2022215-59-2 |
詳細(xì)
|
Cemiplimab |
Cemiplimab |
1801342-60-8 |
詳細(xì)
|
Samrotamab |
Samrotamab |
2052591-32-7 |
詳細(xì)
|
Budigalimab |
Budigalimab |
2098225-93-3 |
詳細(xì)
|
Abelacimab |
Abelacimab |
2098724-83-3 |
詳細(xì)
|
Olinvacimab |
Olinvacimab |
2095504-49-5 |
詳細(xì)
|
Murlentamab |
Murlentamab |
2058047-65-5 |
詳細(xì)
|
Belantamab |
Belantamab |
2061894-48-0 |
詳細(xì)
|
Research Grade Lenvervimab |
倫韋單抗 |
2055006-79-4 |
詳細(xì)
|
Research Grade Ravagalimab |
|
2050816-56-1 |
詳細(xì)
|
Research Grade Leronlimab |
樂(lè)利單抗 |
674782-26-4 |
詳細(xì)
|